Literature DB >> 34221830

A long-term survival case with recurrent esophageal adenosquamous carcinoma.

Koichi Matsuoka1, Masao Hada1, Hayato Ohmori1, Aya Yajima1, Tatsunori Nadaya1, Hideki Watanabe1, Hiroshi Nakagomi1, Toshio Oyama2.   

Abstract

We experienced an extremely rare case of recurrent esophageal adenosquamous carcinoma showing cutis, bone and adrenal gland metastases. Furthermore, the patient showed complete remission by chemotherapy and irradiation, with a long-term survival of over 8 years. A 46-year-old man with esophago-gastric junction cancer of clinical stage II was administered two cycles of neo-adjuvant chemotherapy with FP (5FU 800 mg/mm2 Cisplatin 80 mg/mm2 every 3 weeks), subsequently, underwent esophagectomy and mediastinal and celiac lymph node dissection. However, at 1 month after the surgery, he was admitted again due to a 1 cm cutaneous metastasis at the anterior chest wall and left side adrenal gland metastasis. Furthermore, magnetic resonance imaging showed bone metastasis at the second cervical vertebra. He was administered weekly docetaxel at 40 mg/body (3 times every 4 weeks) for 27 cycles. Irradiation therapy (liniac 36 Gy/16Fr) was performed for the vertebral metastasis. The cutaneous and adrenal metastases were diminished and complete remission persisted for over 8 years. © The Japan Society of Clinical Oncology 2021.

Entities:  

Keywords:  Cutaneous metastases; Esophageal adenosquamous carcinoma; Long-term survival

Year:  2021        PMID: 34221830      PMCID: PMC8206412          DOI: 10.1007/s13691-021-00473-3

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  17 in total

1.  Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.

Authors:  Megumi Hori; Tomohiro Matsuda; Akiko Shibata; Kota Katanoda; Tomotaka Sobue; Hiroshi Nishimoto
Journal:  Jpn J Clin Oncol       Date:  2015-07-03       Impact factor: 3.019

2.  [Survival after cutaneous metastasis: a study of 200 cases].

Authors:  P Schoenlaub; A Sarraux; E Grosshans; E Heid; B Cribier
Journal:  Ann Dermatol Venereol       Date:  2001-12       Impact factor: 0.777

3.  Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.

Authors:  Hugo E R Ford; Andrea Marshall; John A Bridgewater; Tobias Janowitz; Fareeda Y Coxon; Jonathan Wadsley; Wasat Mansoor; David Fyfe; Srinivasan Madhusudan; Gary W Middleton; Daniel Swinson; Stephen Falk; Ian Chau; David Cunningham; Paula Kareclas; Natalie Cook; Jane M Blazeby; Janet A Dunn
Journal:  Lancet Oncol       Date:  2013-12-10       Impact factor: 41.316

Review 4.  Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review.

Authors:  Inmaculada Alcaraz; Lorenzo Cerroni; Arno Rütten; Heinz Kutzner; Luis Requena
Journal:  Am J Dermatopathol       Date:  2012-06       Impact factor: 1.533

Review 5.  [Long-term survival of a patient with esophageal cancer with brain metastasis after multidisciplinary therapy - a case report].

Authors:  Yuji Yamamoto; Hajime Tanaka; Takashi Maruyama; Hiroshi Matsuzaki; Toshiyuki Natsume; Akinari Miyazaki; Yayoi Satoh; Tetsutaro Satsuka; Takafumi Yoshioka; Yoko Kanada; Ryota Otsuka; Akitoshi Yanagihara; Masaya Yokoyama; Takushi Kobayashi
Journal:  Gan To Kagaku Ryoho       Date:  2014-11

6.  Primary adenosquamous carcinoma of the esophagus.

Authors:  Shao-Bin Chen; Hong-Rui Weng; Geng Wang; Jie-Sheng Yang; Wei-Ping Yang; Di-Tian Liu; Yu-Ping Chen; Hao Zhang
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

7.  Clinical Characteristics Associated with Long-term Survival in Metastatic Gastric Cancer after Systemic Chemotherapy.

Authors:  Shigenori Kadowaki; Azusa Komori; Daisuke Takahari; Takashi Ura; Seiji Ito; Masahiro Tajika; Yasumasa Niwa; Isao Oze; Kei Muro
Journal:  Asian Pac J Cancer Prev       Date:  2015

8.  A global assessment of the oesophageal adenocarcinoma epidemic.

Authors:  Gustaf Edgren; Hans-Olov Adami; Elisabete Weiderpass; Elisabete Weiderpass Vainio; Olof Nyrén
Journal:  Gut       Date:  2012-08-23       Impact factor: 23.059

9.  A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003.

Authors:  C Gholipour; R A Shalchi; M Abbasi
Journal:  Dis Esophagus       Date:  2008       Impact factor: 3.429

10.  Five-year Survival After Surgical Removal and Gamma Knife Stereotactic Radiosurgery for a Cerebellar Metastasis from an Esophagogastric Junction Cancer: A Case Report and Literature Review.

Authors:  Yoshikazu Kanazawa; Itsuo Fujita; Daisuke Kakinuma; Yuto Aoki; Hitoshi Kanno; Hiroki Arai; Kunihiko Matsuno; Tomohiro Shimoda; Takeshi Matsutani; Nobutoshi Hagiwara; Tsutomu Nomura; Takeshi Yamada; Shunji Kato; Zenya Naito; Hideaki Takasaki; Eiji Uchida
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.